Home InterVenn BioSciences

InterVenn BioSciences

First Patient Enrolled in the VOCAL Trial

The VOCAL test is a liquid biopsy that combines mass spectrometry and artificial intelligence and machine learning to analyze tumor-associated changes in circulating glycoproteins. The announcement was made at the 2019 ASCO® Annual Meeting in Chicago.